Liontown’s Strategic Pivot: From Defensive Cash Preservation to Growth-Focused Expansion
After a year of restraint, Liontown posts maiden profit and greases the wheels for a capital-efficient expansion as lithium prices triple.
LTR.AX · Earnings Call · 2026-08-30
From Defense to Offense
After a year of disciplined restraint, Liontown Limited has flipped its posture. The lithium miner delivered its maiden profit and is now re-investing in expansion, betting that the market’s sharp recovery is sustainable. As Managing Director Tony Ottaviano put it,
The market has turned. It's turned the way we said we would.
The numbers tell the story: revenue more than doubled to $639 million, operating cash flow hit $182 million, and the company achieved its first underlying net profit after tax of $14 million. The spot price of spodumene concentrate surged from $630 to $2,210 per tonne over the year, a 251% increase, vindicating the team’s decision to preserve cash during the downturn.
Just six months ago, management was focused on liquidity and survival. In November 2024, when prices were weak, they deliberately slowed the underground ramp-up, deferred capital, and pushed out the Northwest Flats project. That defensive posture is now being reversed. The company has recommissioned Northwest Flats, accelerated development, and is readying a final investment decision on a brownfield expansion that could take capacity from 2.8 to 4 million tonnes per year.
“This financial year, Kathleen Valley delivered its maiden profit and a strong operating cash flow while ramping up,” Ottaviano noted. The expansion is capital-efficient because the processing plant was originally designed for 4 million tonnes, so much of the infrastructure is already in place. The Ball mill is the critical path item and early works are underway. “The processing plant was designed and installed for 4 million tonnes per year from the start.” — Antonino Ottaviano, Managing Director and Chief Executive Officer · 2026-08-30
Financial Results and Cost Guidance
For FY26, revenue was a record $639 million, double the prior year, driven by a 35% increase in tonnes shipped and a 75% jump in realized price. Underlying EBITDA rose to $147 million from $20 million. The company generated $182 million in operating cash, a strong result given it was still ramping up. Balance sheet improved dramatically: net debt swung to a net cash position of $561 million, and gross gearing fell from 55% to 20%.
Looking ahead, FY27 guidance reflects investment ahead of production: concentrate production of 390-440 kt, costs of $1,050–$1,250/tonne sold, and total CapEx of $320–370 million (excluding expansion). The higher costs are deliberate. “We are, therefore, not at full run rate and some of that time is investing into the FY '28 ramp-up, but also the expansion,” explained Ottaviano. “The investment ahead of production is what we're doing at present.” — Antonino Ottaviano, Managing Director and Chief Executive Officer · 2026-08-30
Offtake Rebalancing
A significant strategic shift is underway in the offtake portfolio. Historically, Liontown’s contracts were heavily linked to chemical prices (hydroxide and carbonate), which underperformed spodumene. That is now changing. As Chief Commercial Officer Grant Donald explained, “2 of our 3 contracts have chemical reference for CY 2026, but as we move into January, that flips the other way where 2/3 of our product will be linked to spodumene.” The company has also resold some tonnes to Canmax linked to the spodumene index. Spodumene linkage better aligns revenue with the spot market. Grant Donald also noted, “we don't see any issue with meeting our commitments on offtake in FY '27.” — Grant Donald, Chief Commercial Officer · 2026-08-30
This rebalancing should close the gap between realized and spot prices, a key concern for investors in past quarters.
Risks and Uncertainties
Not everything is rosy. Safety metrics deteriorated, with total recordable injury frequency rate up from 7.39 to 10.99, a point management acknowledged. Also, there is a disputed shipment currently under negotiation, though management insists it is not a quality issue. The company will provide more detail on the expansion FID next month, including forward cost guidance.
The prior calls show how far Liontown has come. In November 2024, Ottaviano said: “There may be an optimal throughput that balances your fixed costs, but also your overall costs. We're managing for cash.” — Antonino Ottaviano, Managing Director and CEO · 2024-11-02 And in April 2025, CFO Jon Latto added: “We've taken a pretty prudent view in relation to the current pricing environment and our internal models, we've allowed for spot to continue for quite some time.” — Jon Latto, Chief Financial Officer · 2025-04-24 That prudence is now giving way to confidence, but the execution risk remains.
Liontown is at an inflection point. It has the balance sheet, the asset, and the market tailwind to drive significant value creation. The next few quarters will test whether it can deliver on its expansion promises without losing the discipline that got it through the downturn.